Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Butowski

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022Craig Horbinski, Louis Burt Nabors, Jana Portnow, et al.
JAMA Oncology|February 7, 2020
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed GlioblastomaAnnette M Molinaro, Shawn Hervey-Jumper, Ramin A Morshed, et al.
Nature Genetics|May 9, 2022
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilitiesAbrar Choudhury, Stephen T Magill, Charlotte D Eaton, et al.
Acta Neuropathologica|September 14, 2019
Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomasEmily A Sloan, Tabitha Cooney, Nancy Ann Oberheim Bush, et al.
Acta Neuropathologica Communications|August 30, 2020
Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumorCalixto-Hope G Lucas, Rohit Gupta, Pamela Doo, et al.
Research Square|March 30, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesDavid Raleigh, William Chen, Abrar Choudhury, et al.
Nature Medicine|November 9, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesWilliam C Chen, Abrar Choudhury, Mark W Youngblood, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022Craig Horbinski, Louis Burt Nabors, Jana Portnow, et al.
JAMA Oncology|February 7, 2020
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed GlioblastomaAnnette M Molinaro, Shawn Hervey-Jumper, Ramin A Morshed, et al.
Nature Genetics|May 9, 2022
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilitiesAbrar Choudhury, Stephen T Magill, Charlotte D Eaton, et al.
Acta Neuropathologica|September 14, 2019
Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomasEmily A Sloan, Tabitha Cooney, Nancy Ann Oberheim Bush, et al.
Acta Neuropathologica Communications|August 30, 2020
Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumorCalixto-Hope G Lucas, Rohit Gupta, Pamela Doo, et al.
Research Square|March 30, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesDavid Raleigh, William Chen, Abrar Choudhury, et al.
Nature Medicine|November 9, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesWilliam C Chen, Abrar Choudhury, Mark W Youngblood, et al.
Pageof 10